The carbon source influences the efflux pump-mediated antimicrobial resistance in clinically important Gram-negative bacteria

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 4, 2012, Pages 921-927

  Villagra, Nicolás A ^a   Fuentes, Juan A ^a   Jofré, Matías R ^a   Hidalgo, Alejandro A ^b   García, Patricia ^c   Mora, Guido C ^a  

^a UNIVERSIDAD ANDRÉS BELLO   (Chile)

^b UNIVERSITY AT BUFFALO   (United States)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Alternative carbon source; Antibiotics; Permeases; Resistance mechanisms

Indexed keywords

CARBOHYDRATE; EFFLUX PUMP PROTEIN; INNER MEMBRANE PROTEIN; PHOSPHOTRANSFERASE; PROTEIN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; CARBON SOURCE; DISK DIFFUSION; GENE OVEREXPRESSION; NONHUMAN; PROTEIN SYNTHESIS; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; BIOLOGICAL TRANSPORT, ACTIVE; CARBON; CULTURE MEDIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 84858687800     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr573     Document Type: Article

References (55)

1. McGowan JE Jr. Economic impact of antimicrobial resistance. Emerg Infect Dis 2001; 7: 286-92.
2. Davies JH. Staphylococcal infection by penicillin-resistant strains. Br Med J 1947; 2: 1054.
3. Alekshun MN, Levy SB. Molecular mechanisms of antibacterial multidrug resistance. Cell 2007; 128: 1037-50.
4. Daddi G, Corda M, Grassi C. [Multiresistance of the tubercle bacillus; findings on a second strain of human M. tuberc. containing multiresistant cells]. Boll Ist Sieroter Milan 1958; 37: 125-30.
5. Lafaix C, Camerlynck P, Rey M. [Dakar endemia and hospital epidemic due to multiresistant strains of Salmonella stanleyville. Experimental discovery of extra-chromosomal resistance transferable to Escherichia coli K-12]. Bull Soc Med Afr Noire Lang Fr 1968; 13: 225-33.
6. Spellberg B, Guidos R, Gilbert D et al. The epidemic of antibioticresistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 155-64.
7. Tenover FC. Mechanisms of antimicrobial resistance in bacteria. Am J Infect Control 2006; 34: S3-10; discussion S64-73.
8. Woodford N, Turton JF, Livermore DM. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 2011; 35: 736-55.
9. Maclean RC, Hall AR, Perron GG et al. The evolution of antibiotic resistance: insight into the roles of molecular mechanisms of resistance and treatment context. Discov Med 2010; 10: 112-8.
10. Kitaoka M, Miyata ST, Unterweger D et al. Antibiotic resistance mechanisms of Vibrio cholerae. J Med Microbiol 2011; 60: 397-407.
11. Moore NM, Flaws ML. Antimicrobial resistance mechanisms in Pseudomonas aeruginosa. Clin Lab Sci 2011; 24: 47-51.
12. Piddock LJ. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 2006; 19: 382-402.
13. Poole K. Efflux pumps as antimicrobial resistance mechanisms. Ann Med 2007; 39: 162-76.
14. Davin-Regli A, Bolla JM, James CE et al. Membrane permeability and regulation of drug "influx and efflux" in enterobacterial pathogens. Curr Drug Targets 2008; 9: 750-9.
15. Li XZ, Nikaido H. Efflux-mediated drug resistance in bacteria: an update. Drugs 2009; 69: 1555-623.
16. Martínez JL, Sánchez MB, Martínez-Solano L et al. Functional role of bacterial multidrug efflux pumps in microbial natural ecosystems. FEMS Microbiol Rev 2009; 33: 430-49.
17. Nikaido H. Multidrug resistance in bacteria. Annu Rev Biochem 2009; 78: 119-46.
18. Sato T, Ito K, Yura T. Membrane proteins of Escherichia coli K-12: twodimensional polyacrylamide gel electrophoresis of inner and outer membranes. Eur J Biochem 1977; 78: 557-67.
19. Daley DO, Rapp M, Granseth E et al. Global topology analysis of the Escherichia coli inner membrane proteome. Science 2005; 308: 1321-3.
20. Casadio R, Fariselli P, Finocchiaro G et al. Fishing new proteins in the twilight zone of genomes: the test case of outer membrane proteins in Escherichia coli K12, Escherichia coli O157:H7, and other Gram-negative bacteria. Protein Sci 2003; 12: 1158-68.
21. Siebold C, Flukiger K, Beutler R et al. Carbohydrate transporters of the bacterial phosphoenolpyruvate: sugar phosphotransferase system (PTS). FEBS Lett 2001; 504: 104-11.
22. Ward A, Hoyle C, Palmer S et al. Prokaryote multidrug efflux proteins of the major facilitator superfamily: amplified expression, purification and characterisation. J Mol Microbiol Biotechnol 2001; 3: 193-200.
23. Hillen W, Berens C. Mechanisms underlying expression of Tn10 encoded tetracycline resistance. Annu Rev Microbiol 1994; 48: 345-69.
24. Notley L, Ferenci T. Differential expression of mal genes under cAMP and endogenous inducer control in nutrient-stressed Escherichia coli. Mol Microbiol 1995; 16: 121-9.
25. Deutscher J. The mechanisms of carbon catabolite repression in bacteria. Curr Opin Microbiol 2008; 11: 87-93.
26. Kang HY, Song S, Park C. Priority of pentose utilization at the level of transcription: arabinose, xylose, and ribose operons. Mol Cells 1998; 8: 318-23.
27. Lee JH, Al-Zarban S, Wilcox G. Genetic characterization of the araE gene in Salmonella typhimurium lt2. J Bacteriol 1981; 146: 298-304.
28. Lee JH, Russo RJ, Heffernan L et al. Regulation of L-arabinose transport in Salmonella typhimurium LT2. Mol Gen Genet 1982; 185: 136-41.
29. Nagelkerke F, Postma PW. 2-deoxygalactose, a specific substrate of the Salmonella typhimurium galactose permease: its use for the isolation of galP mutants. J Bacteriol 1978; 133: 607-13.
30. Postma PW. Galactose transport in Salmonella typhimurium. J Bacteriol 1977; 129: 630-9.
31. Shamanna DK, Sanderson KE. Uptake and catabolism of D-xylose in Salmonella typhimurium LT2. J Bacteriol 1979; 139: 64-70.
32. Tate CG, Henderson PJ. Membrane topology of the L-rhamnose-H+ transport protein (RhaT) from enterobacteria. J Biol Chem 1993; 268: 26850-7.
33. Via P, Badia J, Baldoma L et al. Transcriptional regulation of the Escherichia coli rhaT gene. Microbiology 1996; 142: 1833-40.
34. Santiviago CA, Fuentes JA, Bueno SM et al. The Salmonella enterica sv. Typhimurium smvA, yddG and ompD (porin) genes are required for the efficient efflux of methyl viologen. Mol Microbiol 2002; 46: 687-98.
35. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 2000; 97: 6640-5.
36. Santiviago CA, Toro CS, Hidalgo AA et al. Global regulation of the Salmonella enterica serovar Typhimurium major porin, OmpD. J Bacteriol 2003; 185: 5901-5.
37. Rappleye CA, Roth JR. A Tn10 derivative (T-POP) for isolation of insertions with conditional (tetracycline-dependent) phenotypes. J Bacteriol 1997; 179: 5827-34.
38. Bauer AW, Kirby WM, Sherris JC et al. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966; 45: 493-6.
39. Villagra NA, Hidalgo AA, Santiviago CA et al. SmvA, and not AcrB, is the major efflux pump for acriflavine and related compounds in Salmonella enterica serovar Typhimurium. J Antimicrob Chemother 2008; 62: 1273-6.
40. Hidalgo AA, Trombert AN, Castro-Alonso JC et al. Insertions of mini-Tn10 transposon T-POP in Salmonella enterica sv. Typhi. Genetics 2004; 167: 1069-77.
41. Braoudaki M, Hilton AC. Mechanisms of resistance in Salmonella enterica adapted to erythromycin, benzalkonium chloride and triclosan. Int J Antimicrob Agents 2005; 25: 31-7.
42. Nikaido H. Multidrug efflux pumps of gram-negative bacteria. J Bacteriol 1996; 178: 5853-9.
43. Hongo E, Morimyo M, Mita K et al. The methyl viologen-resistanceencoding gene smvA of Salmonella typhimurium. Gene 1994; 148: 173-4.
44. McClelland M, Sanderson KE, Spieth J et al. Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 2001; 413: 852-6.
45. Joardar V, Lindeberg M, Jackson RW et al. Whole-genome sequence analysis of Pseudomonas syringae pv. phaseolicola 1448A reveals divergence among pathovars in genes involved in virulence and transposition. J Bacteriol 2005; 187: 6488-98.
46. Kerr KG, Snelling AM. Pseudomonas aeruginosa: a formidable and ever-present adversary. J Hosp Infect 2009; 73: 338-44.
47. Coyne S, Courvalin P, Perichon B. Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob Agents Chemother 2011; 55: 947-53.
48. Zavascki AP, Carvalhaes CG, Picao RC et al. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy. Expert Rev Anti Infect Ther 2010; 8: 71-93.
49. Pasteran F, Veliz O, Faccone D et al. A simple test for the detection of KPC and metallo-β-lactamase carbapenemase-producing Pseudomonas aeruginosa isolates with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin. Clin Microbiol Infect 2011; 17: 1438-41.
50. Vila J, Martí S, Sánchez-Céspedes J. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J Antimicrob Chemother 2007; 59: 1210-5.
51. Köhler T, Michea-Hamzehpour M, Epp SF et al. Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems. Antimicrob Agents Chemother 1999; 43: 424-7.
52. Pournaras S, Maniati M, Spanakis N et al. Spread of efflux pumpoverexpressing, non-metallo-β-lactamase-producing, meropenemresistant but ceftazidime-susceptible Pseudomonas aeruginosa in a region with blaVIM endemicity. J Antimicrob Chemother 2005; 56: 761-4.
53. Gu Y, Ding Y, Ren C et al. Reconstruction of xylose utilization pathway and regulons in Firmicutes. BMC Genomics 2010; 11: 255.
54. Williams DK, Martin SA. Xylose uptake by the ruminal bacterium Selenomonas ruminantium. Appl Environ Microbiol 1990; 56: 1683-8.
55. Davis EO, Jones-Mortimer MC, Henderson PJ. Location of a structural gene for xylose-H+ symport at 91 min on the linkage map of Escherichia coli K12. J Biol Chem 1984; 259: 1520-5.